Literature DB >> 18205227

Molecular epidemiology of human metapneumovirus in Ireland.

Michael J Carr1, Allison Waters, Fiona Fenwick, Geoffrey L Toms, William W Hall, Edwin O'Kelly.   

Abstract

Human metapneumovirus (hMPV) is a cause of respiratory illness ranging from wheezing to bronchiolitis and pneumonia in children. A quantitative real-time reverse-transcriptase polymerase chain reaction (RT-PCR) assay was developed for the detection of all four main genetic lineages of hMPV and employed to validate an indirect immunofluorescence (IF) assay to detect hMPV positive specimens. The IF assay detected 24 positives from a screen of 625 randomly selected pediatric respiratory specimens collected (3.8% prevalence). From this cohort of 625 specimens, 229 were also tested by real-time RT-PCR assay. This included the 24 IF positive specimens and 205 randomly selected specimens from both study periods. In addition to confirming all the IF positives, the real-time assay detected an additional six hMPV positive specimens giving rise to a combined prevalence of 4.8%. Phylogenetic analysis showed that hMPV subtypes A2b and B2 to be the most prevalent genotypes circulating in our population and surprisingly no hMPV subgroups A1 or B1 were detected during this study period. Based on this phylogenetic analysis, we propose the existence of sub-clusters of hMPV genotype B2 present in our population which we term subtypes B2a and B2b. The mean log 10 copies/ml of quantitative RT-PCR determinations from these 30 hMPV positive respiratory specimens was 6.35 (range = 4.44-8.15). Statistical analysis of quantitative RT-PCR determinations of viral load from these 30 respiratory specimens suggests that hMPV genotype B specimens have a higher viral load than hMPV genotype A isolates (P < 0.03).

Entities:  

Mesh:

Year:  2008        PMID: 18205227     DOI: 10.1002/jmv.21081

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

Review 1.  Human Metapneumovirus: lessons learned over the first decade.

Authors:  Verena Schildgen; Bernadette van den Hoogen; Ron Fouchier; Ralph A Tripp; Rene Alvarez; Catherine Manoha; John Williams; Oliver Schildgen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

2.  Increase human metapneumovirus mediated morbidity following pandemic influenza infection.

Authors:  Liora Regev; Tal Meningher; Musa Hindiyeh; Ella Mendelson; Michal Mandelboim
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

3.  Molecular investigation of human metapneumovirus in children with acute respiratory infections in Chennai, South India, from 2016-2018.

Authors:  Anusha Hindupur; Thangam Menon; Prabu Dhandapani
Journal:  Braz J Microbiol       Date:  2022-02-04       Impact factor: 2.214

4.  Cytokine Profiles in Human Metapneumovirus Infected Children: Identification of Genes Involved in the Antiviral Response and Pathogenesis.

Authors:  Jostein Malmo; Nina Moe; Sidsel Krokstad; Liv Ryan; Simon Loevenich; Ingvild B Johnsen; Terje Espevik; Svein Arne Nordbø; Henrik Døllner; Marit W Anthonsen
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

5.  Patterns of synonymous codon usage on human metapneumovirus and its influencing factors.

Authors:  Qiao Zhong; Weidong Xu; Yuanjian Wu; Hongxing Xu
Journal:  J Biomed Biotechnol       Date:  2012-11-05

6.  Genetic variability of human metapneumo- and bocaviruses in children with respiratory tract infections.

Authors:  Vasiliki Pogka; Afroditi Moutousi; Athanasios Kossyvakis; Antonios Kalliaropoulos; Dionyssios N Sgouras; Maria Giannaki; Andreas F Mentis
Journal:  Influenza Other Respir Viruses       Date:  2013-11-07       Impact factor: 4.380

7.  Human metapneumovirus prevalence and molecular epidemiology in respiratory outbreaks in Ontario, Canada.

Authors:  Alefiya Neemuchwala; Venkata R Duvvuri; Alex Marchand-Austin; Aimin Li; Jonathan B Gubbay
Journal:  J Med Virol       Date:  2014-08-05       Impact factor: 2.327

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.